Description

PharmaQo Superdrol 25 is a pharmaceutical-grade injectable containing 25 mg/mL Methyldrostanolone (Superdrol), designed for investigational research into anabolic effects, nitrogen retention, and tissue-wasting conditions.

This lower-concentration formulation allows for precise dosing in controlled research settings, especially where careful titration and monitoring are required.

Product Details:
Active Ingredient:

• Methyldrostanolone (Superdrol)

Concentration: 25 mg/mL

Form: Injectable solution (intramuscular)

Vial Size: 10 mL multidose vial

Pharmacokinetics:
Injectable Methyldrostanolone bypasses first-pass metabolism, with an approximate half-life of 8–12 hours, often requiring daily or alternate-day administration in research protocols.

Usage Recommendations:

• Indications (Research Context): Investigational use in anabolic support, nitrogen balance, recovery (not for human use)

• Typical Dosage (Research Use): 25–50 mg per day, depending on study design

• Monitoring: Liver enzymes, lipid profile, androgenic effects, cardiovascular parameters

• Cycle/Duration: Short-term, typically 4–6 weeks, based on protocol

Disclaimer:
This product is intended strictly for research and educational purposes. It is not approved for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical conditions. Always comply with local research laws and ethics.